Getty ImagesThe scrip had closed at Rs 182.0 in the previous session. The stock quoted a 52-week low of Rs 133.1 and a high of Rs 191.45. The company quoted a market-cap of Rs 53848.57 crore on the BSE.
On BSE, 190,910 shares have changed hands on the counter so far. At its prevailing price, the stock traded at 30.26 times its trailing 12-month EPS of Rs 6.06 per share and 4.78 times its book value. The return on equity (ROE) stood at Rs 14.57.
Key Financials
For the quarter ended 30-Jun-2023, Ashok Leyland Ltd. reported consolidated sales of Rs 9735.45 crore, down 34.31 per cent from the same quarter a year ago. The company reported 699.25 per cent YoY growth in net profit at Rs 543.89 crore for the latest quarter.
Technical indicators
The relative strength index (RSI) of the stock stood at Friday. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold when it is below 30.
Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a "buy" or "sell" recommendation using a single valuation ratio.
Friday, 08 Sep, 2023- Front Page
- Pure Politics
- ET Markets
- Smart Investing
- Learn more about our print editionMore
IT Hardware Imports Surge in Aug after Licensing OrderIndia’s IT hardware imports surged as much as 50% in August from July, ahead of licensing rules taking effect on November 1. Companies advanced procurements fearing a supply crunch, said manufacturers and a leading system integrator that buys from distributors and producers and supplies to enterprises.
‘Look to Export AI Products from Nvidia India Arm’Nvidia, the world’s pre-eminent maker of hardware and software for artificial intelligence tools, envisions exporting AI products from its Indian arm, CEO and co-founder of the $27-billion firm, Jensen Huang told researchers at India’s top technology institutes this week, according to the people present at the interaction.
DCGI Collating Data of Pharma PlantsAfter a major drive by the government against spurious and substandard drugs, India’s drug regulator has started collating and compiling the profiles of pharmaceutical plants in the country.The Drug Controller General of India (DCGI) has asked drug companies to provide details of each of their units operational in the country.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Get Unlimited Access to The Economic Times 
